Showing results (81-90 of 402) with videos related to

Sort By:
Pageof 41
Expert Review of Anticancer Therapy|June 13, 2020
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectivesGiulia Sartori, Lorenzo Belluomini, Fiorella Lombardo, et al.
Journal of Personalized Medicine|October 27, 2023
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New GloriesMarco Sposito, Lorenzo Belluomini, Letizia Pontolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cellsMichele Milella, Daniela Trisciuoglio, Tiziana Bruno, et al.
Critical Reviews in Oncology/Hematology|July 13, 2024
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to successLorenzo Belluomini, Alice Avancini, Marco Sposito, et al.
Expert Opinion on Biological Therapy|November 8, 2008
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issuesEmilio Bria, Federica Cuppone, Michele Milella, et al.
International Journal of Environmental Research and Public Health|July 30, 2020
Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional StudyAlice Avancini, Valeria Pala, Ilaria Trestini, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|April 14, 2024
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preferenceAnita Borsati, Linda Toniolo, Ilaria Trestini, et al.
Current Pharmaceutical Design|October 22, 2013
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'Sara Pilotto, Maria Bonomi, Francesco Massari, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitorsJames A McCubrey, Michele Milella, Agostino Tafuri, et al.
Cancer|June 29, 2004
Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinomaMichele Milella, Alain Gelibter, Serena Di Cosimo, et al.
Pageof 41